Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Empresa estonia especializada en espectroscopía busca socios para participar en la convocatoria de H2020-EIC-SMEInst-2018-2020 SME-2 Instrumento Pyme en la fase 2

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDEE20171228001
Publicado:
27/02/2018
Caducidad:
01/05/2018
Resumen:
Una pyme estonia con más de 25 años de experiencia en espectroscopía infrarroja por transformada de Fourier (FTIR) busca pymes en el sector de diagnóstico y tratamiento del cáncer. El objetivo es participar en un proyecto SME-2 (H2020-EIC-SMEInst-2018-2020) para obtener muestras in vitro de pacientes con cáncer de mama y muestras de personas sanas. La empresa tendrá en cuenta la capacidad para realizar análisis estadísticos del espectro infrarrojo medido de las muestras in vitro. La fecha límite de la convocatoria es el 23 de mayo de 2018 y el plazo para presentar expresiones de interés finaliza el 1 de mayo. El proyecto tendrá una duración de dos años.

Details

Tittle:
An Estonian spectroscopy company is looking for partners for H2020-EIC-SMEInst-2018-2020 SME-2 SME instrument phase 2
Summary:
An Estonian SME with more than 25 years of experience in the field of Fourier Transform Infrared (FTIR) Spectroscopy is looking for SME partners active in breast cancer diagnostics and treatment. The partners will be involved in the SME-2 project (H2020-EIC-SMEInst-2018-2020) by getting "in vitro" samples from patients with breast cancer and from healthy persons. The capability to carry out statistical analysis of the measured infrared spectra of "in vitro" samples would be highly appreciated.
Description:
The Estonian company has been manufacturing Fourier Transform Infrared (FTIR) spectroscopy instruments since 1991. The company´s instruments have been used in many fields and applications, including analytical chemistry, food, environment, biomedical and academic research.

During these years, the company has been engaged in the development of infrared and near-infrared Fourier transform (FTIR) spectrometers for laboratory as well as for field use. The company´s scientists and engineers have extensive research and development expertise regarding infrared and near infrared spectroscopic equipment. For instance, they have previously developed a series of infrared space-borne spectrometers for atmospheric research.

The company has previously participated in several national and international projects connected with the development of innovative FTIR spectrometers. Now, they are putting together a consortium for the H2020-EIC-SMEInst-2018-2020 SME-2 SME instrument phase 2 call. The proposal will be submitted by 23 May 2018 and the company is expecting partner offers until 1 May 2018. The project activities are planned for ca. 2 years.
Advantages and Innovations:
The main innovation of the technology is in the developed non-invasive remote screening method for breast cancer screening. The method is using infrared spectroscopy to non-invasively detect molecular changes in women who have cancer. Specifically, infrared spectroscopy of women´s "in vitro" samples will be used to measure these changes.

The analysis can be done remotely - "in vitro" samples can be sent to a laboratory in an envelope to the analyzing center. The attenuated total reflection (ATR) measurement technique will be used as the basic sample handling and measuring technique.
Stage of Development:
Proposal under development
IPR Status:
Secret Know-how

Partner sought

Partner Sought:
The partners are expected to be involved in getting "in vitro" samples from patients with breast cancer and the same samples from healthy persons. Involvement in the further measurement of the gathered samples and in statistical analysis of the infrared spectra of "in vitro" samples would be highly appreciated. These partners would have to be SMEs, e.g. private medical (research) centers and clinics. All in all, the company is looking for a partner who has the necessary expertise and know-how to take responsibility for the following activities: *gathering "in vitro" samples from patients with and without breast cancer; *measuring the "in vitro" samples with an FTIR spectrometer; *analyzing the measured spectra statistically.
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
Industry SME <= 10
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English

Dissemination

Programme-call

Framwork Programme:
H2020
Anticipated Project Budget:
2 MEUR
Coordinator Required:
No
Deadline for Call:
23/05/2018